CN115335075A - 治疗和预防乙型肝炎和丁型肝炎的组合物和方法 - Google Patents

治疗和预防乙型肝炎和丁型肝炎的组合物和方法 Download PDF

Info

Publication number
CN115335075A
CN115335075A CN202180022581.7A CN202180022581A CN115335075A CN 115335075 A CN115335075 A CN 115335075A CN 202180022581 A CN202180022581 A CN 202180022581A CN 115335075 A CN115335075 A CN 115335075A
Authority
CN
China
Prior art keywords
arg
gly
glu
lys
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180022581.7A
Other languages
English (en)
Chinese (zh)
Inventor
马蒂·萨尔伯格
拉尔斯·弗雷林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sweden Vaccine Pharmaceutical Co ltd
Original Assignee
Sweden Vaccine Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sweden Vaccine Pharmaceutical Co ltd filed Critical Sweden Vaccine Pharmaceutical Co ltd
Publication of CN115335075A publication Critical patent/CN115335075A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/10011—Arenaviridae
    • C12N2760/10111—Deltavirus, e.g. hepatitis delta virus
    • C12N2760/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Beans For Foods Or Fodder (AREA)
CN202180022581.7A 2020-01-28 2021-01-26 治疗和预防乙型肝炎和丁型肝炎的组合物和方法 Pending CN115335075A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062966970P 2020-01-28 2020-01-28
US62/966,970 2020-01-28
PCT/US2021/015126 WO2021154752A1 (en) 2020-01-28 2021-01-26 Compositions and methods for treating and preventing hepatitis b and d

Publications (1)

Publication Number Publication Date
CN115335075A true CN115335075A (zh) 2022-11-11

Family

ID=74673345

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180022581.7A Pending CN115335075A (zh) 2020-01-28 2021-01-26 治疗和预防乙型肝炎和丁型肝炎的组合物和方法

Country Status (9)

Country Link
US (1) US20230079898A1 (cg-RX-API-DMAC7.html)
EP (1) EP4096711A1 (cg-RX-API-DMAC7.html)
JP (1) JP7855515B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220149519A (cg-RX-API-DMAC7.html)
CN (1) CN115335075A (cg-RX-API-DMAC7.html)
AU (1) AU2021214939A1 (cg-RX-API-DMAC7.html)
CA (1) CA3169407A1 (cg-RX-API-DMAC7.html)
MX (1) MX2022009169A (cg-RX-API-DMAC7.html)
WO (1) WO2021154752A1 (cg-RX-API-DMAC7.html)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101564533A (zh) * 2009-06-12 2009-10-28 东南大学 戊型肝炎蛋白-核酸复合疫苗及其制备方法
CN102895659A (zh) * 2011-07-29 2013-01-30 复旦大学 一种防治老年痴呆症复合疫苗及其制备方法
WO2017132332A1 (en) * 2016-01-28 2017-08-03 Svenska Vaccinfabriken Produktion Ab Chimeric hepatitis d virus antigen and hepatitis b virus pre s1 genes for use alone or in vaccines contaning hepatitis b virus genes
US20190209677A1 (en) * 2016-09-21 2019-07-11 The Governors Of The University Of Alberta Hepatitis c virus immunogenic compositions and methods of use thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101564533A (zh) * 2009-06-12 2009-10-28 东南大学 戊型肝炎蛋白-核酸复合疫苗及其制备方法
CN102895659A (zh) * 2011-07-29 2013-01-30 复旦大学 一种防治老年痴呆症复合疫苗及其制备方法
WO2017132332A1 (en) * 2016-01-28 2017-08-03 Svenska Vaccinfabriken Produktion Ab Chimeric hepatitis d virus antigen and hepatitis b virus pre s1 genes for use alone or in vaccines contaning hepatitis b virus genes
US20190209677A1 (en) * 2016-09-21 2019-07-11 The Governors Of The University Of Alberta Hepatitis c virus immunogenic compositions and methods of use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
章德广: "初免加强免疫增强肺炎链球菌表面黏附素(psaA)核酸疫苗免疫原性研究", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》, no. 12, 15 December 2009 (2009-12-15), pages 059 - 59 *

Also Published As

Publication number Publication date
JP7855515B2 (ja) 2026-05-08
AU2021214939A1 (en) 2022-09-15
KR20220149519A (ko) 2022-11-08
JP2023512526A (ja) 2023-03-27
CA3169407A1 (en) 2021-08-05
EP4096711A1 (en) 2022-12-07
US20230079898A1 (en) 2023-03-16
WO2021154752A1 (en) 2021-08-05
MX2022009169A (es) 2022-12-08

Similar Documents

Publication Publication Date Title
AU2019202515B2 (en) Vaccine composition
EP2391383B1 (en) Codon-optimized hepatitis b virus core antigen (hbcag)
KR20200101416A (ko) B형 간염 바이러스(hbv) 백신 및 그 용도
US7223743B2 (en) Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
CN111918666A (zh) 一种新型疫苗佐剂
US20190083607A1 (en) Chimeric hepatitis d virus antigen and hepatitis b virus pre s1 genes for use alone or in vaccines contaning hepatitis b virus genes
JP4970435B2 (ja) フィブロネクチンのedaドメインの使用を基にした剤および方法
CN114340664A (zh) 乙型肝炎病毒(HBV)疫苗和靶向HBV的RNAi的组合
TW202202623A (zh) 治療和預防冠狀病毒之成分和方法
CN105367662B (zh) 一种hbv相关的融合蛋白、其制备方法及其应用
RU2812764C1 (ru) Композиции и способы для лечения и предотвращения гепатита в и d
HK40083708A (en) Compositions and methods for treating and preventing hepatitis b and d
JP7855515B2 (ja) B型肝炎およびd型肝炎を治療および予防するための組成物および方法
US20250197452A1 (en) Compositions and methods for treating and preventing hepatitis b and d
ES2299626T3 (es) Aumento de timosina para asegurar una inmunizacion genetica.
JP2026022933A (ja) B型肝炎ウイルスワクチン
AU2002360315B2 (en) Thymosin augmentation of genetic immunization
JPWO2005090576A1 (ja) 百日咳感染症予防用dna構築物
US20140286985A1 (en) Simple vaccines from dna launched suicidal flaviviruses
HK1165694B (en) Codon-optimized hepatitis b virus core antigen (hbcag)
GB2440528A (en) Antigen-antibody complexes
AU2002360315A1 (en) Thymosin augmentation of genetic immunization

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40083708

Country of ref document: HK